Skip to main content
. 2019 Feb 8;3(2):nzy096. doi: 10.1093/cdn/nzy096

FIGURE 1.

FIGURE 1

Tissue VA (as retinol + retinyl esters), determined by HPLC (liver and serum) or UPLC (adipose tissue) in Studies 1 (black circles), 2 (dark grey squares), and 3 (light grey triangles). RP tissue was only available in Studies 1 and 3. (A, B) Inline graphic Example cutoff for deficiency for Studies 1 and 2. Inline graphic Example cutoff for deficiency for Study 3. (A) Liver and EPI retinol concentrations. The data point with an open symbol was an outlier and excluded from further analysis. A further outlier at (0.33, 6.50) was off-axis and also excluded. (B) Liver and RP retinol concentrations. (C–F) ANCOVA including liver, serum, and either EPI (C, E) or RP (D, F) tissue VA was performed after base-10 logarithmic transformation of liver and adipose VA concentrations in Studies 1 (Inline graphic), 2 (—), and 3 (– – –), with study as a covariate. (C, D) Liver VA concentration explained 28% (D, EPI) and 57% (E, RP) of the variation in adipose VA concentration (< 0.001). (E, F) Serum retinol concentration explained a negligible fraction of the variation in adipose VA concentration. EPI, epididymal adipose; RP, retroperitoneal adipose; UPLC, ultra-performance LC; VA, vitamin A.